BLIN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BLIN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near $1.03 with only a small daily gain, but the technical setup is not showing a strong breakout, proprietary signals are absent, and the latest quarter shows revenue growth alongside worsening profitability. Based on the current data, the better decision is to hold and wait for clearer momentum and improved fundamentals before committing capital.
Current price is 1.03, just above the pivot at 0.988 and below resistance at 1.057 and 1.10. RSI_6 at 61.593 is neutral-to-slightly bullish, but MACD histogram is positive and contracting, which suggests momentum is weakening rather than accelerating. Moving averages are converging, indicating a range-bound or indecisive trend. The short-term pattern data also points to downside bias, with a 60% chance of roughly -1.02% next day, -0.98% next week, and -6.21% next month. Overall, the current trend is weak and not attractive for an impatient long-term entry.
Revenue in 2026/Q1 increased 3.22% year over year to 3.913 million, showing the business is still growing top line. The stock is trading above pivot support, and there was a modest regular-session gain of 1.00%, suggesting some near-term stabilization. AI Stock Picker and SwingMax both show no signal today, which at least means there is no conflicting aggressive sell signal from the proprietary system.
Net income fell to -86,000 in 2026/Q1, EPS dropped to -0.01, and gross margin also declined slightly year over year, showing profitability pressure. There was no news in the recent week, so no fresh catalyst is supporting the share price. Hedge funds and insiders are both neutral, with no significant trading trends over the last quarter or month. The technical pattern outlook is negative over the next month. No recent congress trading data and no major politician or influential figure transactions were provided. No valuation data is available, but the lack of strong fundamental or sentiment support keeps the outlook weak.
Latest quarter: 2026/Q1. Revenue rose 3.22% year over year to 3.913 million, which is a modest positive growth trend. However, profitability deteriorated: net income fell to -86,000, EPS declined to -0.01, and gross margin slipped to 61.28%. This shows the company is growing revenue but not yet translating that into improved earnings performance.
No analyst rating or price target change data was provided, so there is no visible recent Wall Street upgrade/downgrade trend to support a bullish view. In practical terms, the Wall Street pros and cons balance is neutral-to-bearish: the bullish case is modest revenue growth, while the bearish case is weak profitability, no recent news catalyst, no insider/hedge fund accumulation, and no proprietary buy signal.
